Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Investigating the prognostic value of TP53 and PIK3CA mutations in metastatic colorectal cancer (mCRC): Applying Structured Query Language (SQL) algorithms to real-world data from a high-volume U.K. tertiary cancer center.
Authors
Caroline Fong
The Royal Marsden NHS Foundation Trust, London and Sutton, United Kingdom;
Caroline Fong , Ali Abdulnabi Suwaidan , Geraldo Alves de Paula Neto , Marion Teare , Elli Bourmpaki , Clare Peckitt , David J. Watkins , Sheela Rao , Naureen Starling , Ian Chau , David Cunningham
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
DOI
10.1200/JCO.2022.40.4_suppl.057
Abstract #
57
Poster Bd #
C8
Abstract Disclosures
Similar Posters
First Author: Sandra Algaze
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Association of class II and III BRAF mutations with EGFR blockade therapy response and representation of molecularly distinct subgroups of BRAF mutations in MMR proficient CRC.
First Author: Ibrahim Halil Sahin
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Tumor genomics and sidedness to predict outcomes in metastatic colorectal cancer (mCRC).
First Author: Patrick M Boland
Poster
2022 ASCO Annual Meeting
The prognostic significance of TP53 mutations in patients with right-sided and left-sided colorectal cancer.
First Author: Moh'd M. Khushman